Functional differences between wild‐type and mutant‐type BRCA1‐associated protein 1 tumor suppressor against malignant mesothelioma cellsShuhei Hakiri, Yoshitaka Sekido|Cancer Science|2015Cited by 35
Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectivelyTatsuhiro Sato, Yoshitaka Sekido|Cancer Cell International|2021Cited by 11
Aberrant expression of <scp><i>NPPB</i></scp> through <scp>YAP1</scp> and <scp>TAZ</scp> activation in mesothelioma with Hippo pathway gene alterationsTatsuhiro Sato, Yoshitaka Sekido|Cancer Medicine|2023Cited by 6
Silencing of SmgGDS, a Novel mTORC1 Inducer That Binds to RHEBs, Inhibits Malignant Mesothelioma Cell ProliferationTatsuhiro Sato, Yoshitaka Sekido|Molecular Cancer Research|2021Cited by 5
Epithelioid Mesothelioma Cells Exhibit Increased Ferroptosis Sensitivity Compared to Non-Epithelioid Mesothelioma CellsTatsuhiro Sato, Yoshitaka Sekido|Cancers|2025Cited by 1